Mediclinic International PLC (MDC) Rating Reiterated by Citigroup Inc.
Mediclinic International PLC (LON:MDC)‘s stock had its “neutral” rating restated by stock analysts at Citigroup Inc. in a report issued on Tuesday.
Several other equities research analysts have also recently issued reports on the company. Jefferies Group LLC cut their target price on Mediclinic International PLC from GBX 650 ($8.55) to GBX 550 ($7.23) and set an “underperform” rating for the company in a research note on Monday, September 25th. J P Morgan Chase & Co cut Mediclinic International PLC to a “neutral” rating and cut their target price for the stock from GBX 898 ($11.81) to GBX 733 ($9.64) in a research note on Thursday, October 19th. Macquarie cut their target price on Mediclinic International PLC from GBX 760 ($10.00) to GBX 660 ($8.68) and set a “neutral” rating for the company in a research note on Friday, October 20th. Finally, Credit Suisse Group raised their target price on Mediclinic International PLC from GBX 265 ($3.49) to GBX 305 ($4.01) and gave the stock a “neutral” rating in a research note on Thursday, October 26th. Two analysts have rated the stock with a sell rating and seven have assigned a hold rating to the company. The stock currently has an average rating of “Hold” and an average price target of GBX 701.44 ($9.23).
Mediclinic International PLC (MDC) traded up GBX 16.50 ($0.22) during trading hours on Tuesday, hitting GBX 525 ($6.91). The company had a trading volume of 3,366,043 shares, compared to its average volume of 1,890,000. Mediclinic International PLC has a 12-month low of GBX 555.50 ($7.31) and a 12-month high of GBX 890.18 ($11.71).
WARNING: This piece was originally posted by American Banking News and is owned by of American Banking News. If you are accessing this piece on another site, it was stolen and republished in violation of international copyright & trademark laws. The legal version of this piece can be viewed at https://www.americanbankingnews.com/2017/11/23/mediclinic-international-plc-mdc-rating-reiterated-by-citigroup-inc.html.
Mediclinic International plc is an international private healthcare provider. The Company’s segments include Mediclinic Southern Africa, Mediclinic Switzerland, Mediclinic Middle East, United Kingdom and Corporate. It focuses on providing acute care and multidisciplinary healthcare services. It has interest in Spire Healthcare, a United Kingdom-based private healthcare company.
Receive News & Ratings for Mediclinic International PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mediclinic International PLC and related companies with MarketBeat.com's FREE daily email newsletter.